Dysplasia in Barrett esophagus
Authors:
- Melanie SimmonsMSMelanie Simmons
- Sapna SyngalSSSapna Syngal
- Robert S. BresalierRBRobert S. Bresalier
- Laurie FortlageLFLaurie Fortlage
- Daniel NormolleDNDaniel Normolle
- Kent A. GriffithKGKent A. Griffith
- Dean E. BrennerDBDean E. Brenner
Open Access
Abstract
BACKGROUND: Dysplasia in Barrett esophagus is a premalignant condition that is associated with an increased risk of developing esophageal adenocarcinoma. Unfortunately, clinical investigation aimed at prevention of progression to malignant disease has been hampered by the variable prevalence of dysplasia reported in the literature. The objective of the current study was to more accurately determine the prevalence of dysplasia among individuals with Barrett esophagus who would be available for enrollment in a chemoprevention trial.METHODS: The pathology archives of 3 institutions were reviewed over a 5‐year period for all reports of diagnoses of Barrett esophagus. Surgical cases, malignancies, and duplicate or referral cases were excluded from the analysis.RESULTS: A total of 790 cases of Barrett esophagus were identified. Of these, 37 (4.7%) were cases of low‐grade dysplasia (LGD), and 20 (2.5%) were cases of high‐grade dysplasia. The University of Michigan Medical Center (Ann Arbor, MI) diagnosed 18 cases of LGD, Henry Ford Hospital (Detroit, MI) diagnosed 15 cases of LGD, and Brigham and Women's Hospital (Boston, MA) diagnosed 4 cases of LGD in patients with Barrett esophagus over the 5‐year study period.CONCLUSIONS: The confirmed low prevalence of cases of LGD will affect the design of future clinical trials of chemopreventive interventions for Barrett esophagus. Cancer 2004. © 2004 American Cancer Society.Keywords
This publication has 27 references indexed in Scilit:
- Reproducibility of the diagnosis of dysplasia in Barrett esophagus: A reaffirmationHuman Pathology, 2001
- Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomasMolecular Carcinogenesis, 1998
- Barrett's Esophagus with High-Grade DysplasiaAnnals of Surgery, 1996
- Adenocarcinoma of the esophagogastric junction and Barrett's esophagusGastroenterology, 1995
- Prevalence of metaplasia at the gastro-oesophageal junctionThe Lancet, 1994
- Barrett's esophagus with high-grade dysplasia: An indication for esophagectomy?The Annals of Thoracic Surgery, 1992
- Flow-cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohortGastroenterology, 1992
- Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus.Gut, 1991
- Observer variation in the diagnosis of dysplasia in Barrett's esophagusHuman Pathology, 1988
- Adenocarcinoma Complicating Columnar Epithelium-lined (Barrett’s) EsophagusAmerican Journal of Clinical Pathology, 1978